As a specific antibody targeting CD147ECD was found to inhibit CD147 shedding and sequential CD147ICD release, this might be a part of the reason why CD147 antibody could enhance the sensitivity of cancer cells to paclitaxel [36]. This evidence concerns the gene BSG and cancer.